s6y

APPLIED NEUROSOLUTIONS INC

CIK
872947
Industry
Biological Products, (No Diagnostic Substances)
Formerly
HEMOXYMED INC, OPHIDIAN PHARMACEUTICALS INC

Financials 28

  1. 10-Q Quarterly Report for period ending Mar 31, 2010
  2. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2010
  3. 10-K Annual Report for period ending Dec 31, 2009
  4. 10-Q Quarterly Report for period ending Sep 30, 2009
  5. 10-Q Quarterly Report for period ending Jun 30, 2009
  6. 10-Q Quarterly Report for period ending Mar 31, 2009
  7. 10-K Annual Report for period ending Dec 31, 2008
  8. 10-Q Quarterly Report for period ending Sep 30, 2008
  9. 10-Q Quarterly Report for period ending Jun 30, 2008
  10. 10-Q Quarterly Report for period ending Mar 31, 2008

All 28 financials filings

News 59

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 59 news filings

Ownership 131

  1. SC 13G/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13G/A Major Shareholders
  5. SC 13G/A Major Shareholders
  6. SC 13G/A Major Shareholders
  7. SC 13G/A Major Shareholders
  8. SC 13G Major Shareholders
  9. SC 13G Major Shareholders
  10. SC 13G/A Major Shareholders

All 131 ownership filings

Prospectus 24

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  10. 424B3 Prospectus filed pursuant to Rule 424(b)(3)

All 24 prospectus filings

Proxies 16

  1. DEF 14A Definitive proxy statements
  2. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  3. DEF 14A Definitive proxy statements
  4. PRER14A Preliminary revised proxy soliciting materials
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEF 14C Definitive information statements
  7. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  8. DEFR14C Definitive revised information statement materials
  9. DEF 14C Definitive information statements
  10. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

All 16 proxies filings

Other 74

  1. REVOKED
  2. EFFECT Notice of Effectiveness
  3. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  4. EFFECT Notice of Effectiveness
  5. EFFECT Notice of Effectiveness
  6. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  7. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  8. 10KSB
  9. 10QSB
  10. EFFECT Notice of Effectiveness

All 74 other filings